How the sector creates value
Where do time, compliance and temperature control become an advantage?
R&D and ingredientsGMP productionQuality releaseTemperature-controlled distribution
pharma · sector view
Pharma & Biotech
Where do time, compliance and temperature control become an advantage? The shortest pharmaceutical route is not necessarily the most dependable: customs dwell, breaks in custody and temperature instability can disrupt access. With Iran as the reference, routes should be compared by actual time, reliability and regulatory fit.
Build an opportunity case
Where geography meets infrastructure
Geography becomes economically relevant when a sector meets a working corridor, node or project. Each connection carries its evidence state and source; proximity alone is not proof of demand.
- GMP, traceability and quality-control requirements
- Connection to relevant corridors, nodes and infrastructure
Related provinces and nodes
- ProvinceInsufficient data · The current atlas has no source-backed, contextual sector-to-province relation.Source: not recorded
- Node / placeInsufficient data · The current atlas has no source-backed, contextual sector-to-node / place relation.Source: not recorded
Routes, markets and alternatives
Corridors cut across sectors; they are not sectors themselves. A route may improve access to a market, but a mapped connection alone does not prove demand or performance.
Corridor links
- CorridorInsufficient data · The current atlas has no source-backed, contextual sector-to-corridor relation.Source: not recorded
Recorded markets
- MarketInsufficient data · The current atlas has no source-backed, contextual sector-to-market relation.Source: not recorded
From infrastructure gap to project
Temperature-controlled hubRegional contract manufacturingPharmaceutical distribution center
Projects in the source record
- ProjectInsufficient data · The current atlas has no source-backed, contextual sector-to-project relation.Source: not recorded
What enables or constrains delivery?
Recorded incentives
- Incentives are recorded only with an official source and validity date
- Synergy with connected infrastructure and markets
Decision constraints
- Demand, product registration and access to destination markets
- Cold-chain stability and customs-clearance time
- GMP, traceability and quality-control requirements
Who may invest, and what can be measured?
Investor groups
- Pharmaceutical manufacturers
- Life-science funds
- Cold-chain operators
What the indicators can support
- Registration lead timeInsufficient data · The sector taxonomy names this indicator, but the current data has no numeric observation with unit, period, geography, and row-level source.Value / unit / period / geography / source: — / — / — / — / —
- Temperature excursionsInsufficient data · The sector taxonomy names this indicator, but the current data has no numeric observation with unit, period, geography, and row-level source.Value / unit / period / geography / source: — / — / — / — / —
- Validated capacityInsufficient data · The sector taxonomy names this indicator, but the current data has no numeric observation with unit, period, geography, and row-level source.Value / unit / period / geography / source: — / — / — / — / —
Data confidence: provisional — evidence coverage varies by corridor and project
What the evidence shows, and what is still missing
Observed · app/data/sector-lenses.json · $.sectors[?(@.id='pharma')] · confidence: provisional
- Demand, product registration and access to destination markets
- Cold-chain stability and customs-clearance time
- GMP, traceability and quality-control requirements
What is known about impact in Iran
Iran remains the reference point. The current data records no independent impact observation at province or sector level. That is a gap in evidence, not evidence of no impact.
Provinces: 0/31 observed · Sectors: 0/15 observed
All matrix cells and evidence state
31 provinces
- آذربایجان شرقی · Insufficient data
- آذربایجان غربی · Insufficient data
- اردبیل · Insufficient data
- اصفهان · Insufficient data
- البرز · Insufficient data
- ایلام · Insufficient data
- بوشهر · Insufficient data
- تهران · Insufficient data
- چهارمحال و بختیاری · Insufficient data
- خراسان جنوبی · Insufficient data
- خراسان رضوی · Insufficient data
- خراسان شمالی · Insufficient data
- خوزستان · Insufficient data
- زنجان · Insufficient data
- سمنان · Insufficient data
- سیستان و بلوچستان · Insufficient data
- فارس · Insufficient data
- قزوین · Insufficient data
- قم · Insufficient data
- کردستان · Insufficient data
- کرمان · Insufficient data
- کرمانشاه · Insufficient data
- کهگیلویه و بویراحمد · Insufficient data
- گلستان · Insufficient data
- گیلان · Insufficient data
- لرستان · Insufficient data
- مازندران · Insufficient data
- مرکزی · Insufficient data
- هرمزگان · Insufficient data
- همدان · Insufficient data
- یزد · Insufficient data
15 sectors
- Real Estate & Construction · Insufficient data
- Tourism & Quality of Life · Insufficient data
- Transport & Logistics · Insufficient data
- Energy · Insufficient data
- Agriculture & Food Processing · Insufficient data
- Financial Services · Insufficient data
- Chemicals · Insufficient data
- Mining & Metals · Insufficient data
- Healthcare Services & Devices · Insufficient data
- Advanced Manufacturing · Insufficient data
- Pharma & Biotech · Insufficient data
- Environmental Services · Insufficient data
- Human Capital & Innovation · Insufficient data
- Information & Communication Technology · Insufficient data
- Aerospace & Defense · Insufficient data